Currently, my research focuses on the evaluation of brain and spinal cord distribution, axonal transport, and cellular specificity of different serotypes of adeno-associated viral vectors (AAV) after brain parenchymal and cerebrospinal fluid delivery.

My interests also include the characterization of new capsid-engineered vectors, the deep understanding of the immunological consequences after AAV delivery into the central nervous system, and the development of AAV-based therapeutic platforms for neurological diseases.